Literature DB >> 15860457

Transcriptional regulation of nanog by OCT4 and SOX2.

David J Rodda1, Joon-Lin Chew, Leng-Hiong Lim, Yuin-Han Loh, Bei Wang, Huck-Hui Ng, Paul Robson.   

Abstract

Nanog, Sox2, and Oct4 are transcription factors all essential to maintaining the pluripotent embryonic stem cell phenotype. Through a cooperative interaction, Sox2 and Oct4 have previously been described to drive pluripotent-specific expression of a number of genes. We now extend the list of Sox2-Oct4 target genes to include Nanog. Within the Nanog proximal promoter, we identify a composite sox-oct cis-regulatory element essential for Nanog pluripotent transcription. This element is conserved over 250 million years of cumulative evolution within the eutherian mammals. A Nanog proximal promoter-EGFP (enhanced green fluorescent protein) reporter transgene recapitulates endogenous Nanog mRNA expression in embryonic stem cells and their differentiated derivatives. Sox2 and Oct4 interaction with the Nanog promoter was confirmed through mutagenesis and in vitro binding assays. Electrophoretic mobility shift assays indicate that the Sox2-Oct4 heterodimer forms more efficiently on the composite element within Nanog than the similar element within Fgf4. Using chromatin immunoprecipitation, we show that Oct4 and Sox2 bind to the Nanog promoter in living mouse and human embryonic stem cells. Furthermore, by specific knockdown of Oct4 and Sox2 mRNA by RNA interference in embryonic stem cells, we provide genetic evidence for a link between Oct4, Sox2, and the Nanog promoter. These studies extend the understanding of the pluripotent genetic regulatory network within which the Sox2-Oct4 complex are at the top of the regulatory hierarchy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15860457     DOI: 10.1074/jbc.M502573200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  398 in total

Review 1.  The role of epigenetic regulation in stem cell and cancer biology.

Authors:  Lilian E van Vlerken; Elaine M Hurt; Robert E Hollingsworth
Journal:  J Mol Med (Berl)       Date:  2012-06-02       Impact factor: 4.599

2.  The human embryonic stem cell proteome revealed by multidimensional fractionation followed by tandem mass spectrometry.

Authors:  Peng Zhao; Thomas C Schulz; Eric S Sherrer; D Brent Weatherly; Allan J Robins; Lance Wells
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

Review 3.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

Review 4.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

5.  Cloning and characterization of buffalo NANOG gene: alternative transcription start sites, splicing, and polyadenylation in embryonic stem cell-like cells.

Authors:  Natwar Singh; Ruchi Sharma; Aman George; Suresh K Singla; Prabhat Palta; Radhaysham Manik; Manmohan S Chauhan; Dheer Singh
Journal:  DNA Cell Biol       Date:  2011-10-19       Impact factor: 3.311

6.  ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4.

Authors:  Myoung Ok Kim; Sung-Hyun Kim; Yong-Yeon Cho; Janos Nadas; Chul-Ho Jeong; Ke Yao; Dong Joon Kim; Dong-Hoon Yu; Young-Sam Keum; Kun-Yeong Lee; Zunnan Huang; Ann M Bode; Zigang Dong
Journal:  Nat Struct Mol Biol       Date:  2012-02-05       Impact factor: 15.369

Review 7.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

Review 8.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

9.  Loss of RBBP4 results in defective inner cell mass, severe apoptosis, hyperacetylated histones and preimplantation lethality in mice†.

Authors:  Xiaosu Miao; Tieqi Sun; Holly Barletta; Jesse Mager; Wei Cui
Journal:  Biol Reprod       Date:  2020-06-23       Impact factor: 4.285

10.  Reversible Disruption of Specific Transcription Factor-DNA Interactions Using CRISPR/Cas9.

Authors:  S Ali Shariati; Antonia Dominguez; Shicong Xie; Marius Wernig; Lei S Qi; Jan M Skotheim
Journal:  Mol Cell       Date:  2019-05-02       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.